FP-008

N/A

Report date: 2025/12/02 20:00:12
NME

Base Information

Drug NameFP-008
Drug Alias NameFP-008
ClassificationSmall molecules > Heterocyclic drugs
Mechanisms of ActionInsulin-like growth factor I inhibitors
TargetsInsulin-like growth factor I
Therapy Area/IndicationsDiabetic Retinopathy
Global Approved IndicationsN/A
Approved Indications in ChinaN/A
Original Approved Country/TerritoryN/A
Original Approved DateN/A
Country/TerritoryTaiwan
CombinationsNo
Global Highest StatusDiscontinued (Preclinical)
Highest Status in ChinaN/A
Originator CompaniesForesee Pharmaceuticals Co Ltd
China Registration ClassN/A

Develop Information

Active CompaniesN/A
Inactive CompaniesForesee Pharmaceuticals Co Ltd
Active IndicationsN/A
Inactive IndicationsDiabetic Retinopathy

Other Information

ATC CodeN/A
Related LinksN/A